Ophthalmic Genetics and Gene Therapy

Gene therapy is an exploratory technique that employs genes to treat or prevent diseases. In near future, this technique may include a doctor replacing the mutated gene with a healthy copy of the gene to the patient in order to cure the abnormalities instead of surgery or drugs. Ophthalmic genetics is a branch of ophthalmology which refers to the field where the genetic background of disease is researched. Leber Congenital Amaraius(LCA) is a hereditary genetic disease that causes childhood blindness. Scientists and doctors have treated this disease with the help of gene therapy.

  • Genetics of Myopia Development
  • Gene Therapy
  • Usher syndrome
  • Familial exudative vitreal retinopathy
  • Retinoblastoma
  • Leber hereditary optic neuropathy (LHON)
  • Optic atrophy
  • Genetics of Myopia Development

Related Conference of Ophthalmic Genetics and Gene Therapy

August 03-04, 2022

19th International Conference on Metabolomics

Zurich, Switzerland
August 10-10, 2022

3rd International Conference on Optometry

Amsterdam, Netherlands
August 11-12, 2022

5th International Conference on Eye and Vision

Berlin, Germany
September 01-01, 2022

5th World Eye and Vision Congress

Amsterdam, Netherlands
September 26-27, 2022

32nd International Congress on Vision Science and Eye

Rome, Italy
October 03-04, 2022

3rd World Congress on Ophthalmology & Optometry

London, UK
October 10-11, 2022

36th European Ophthalmology Congress

Vienna, Austria
October 11-12, 2022

6th World Congress on Eye and Vision

Osaka, Japan
October 11-12, 2022

3rd International Conference on Glaucoma

Osaka, Japan
November 02-02, 2022

2nd International Conference on Ophthalmology

Prague, Czech Republic
November 21-22, 2022

32nd World Congress on Ophthalmology and Optometry

Rome, Italy

Ophthalmic Genetics and Gene Therapy Conference Speakers

Recommended Sessions

Related Journals

Are you interested in